S Perreault

Summary

Country: Canada

Publications

  1. ncbi Efficacy and cost of HMG-CoA reductase inhibitors in the treatment of patients with primary hyperlipidemia
    S Perreault
    University of Montreal, Montreal, Canada
    Can J Clin Pharmacol 7:144-54. 2000
  2. pmc Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention
    S Perreault
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec H3C 3J7, Canada
    Br J Clin Pharmacol 59:564-73. 2005

Collaborators

Detail Information

Publications2

  1. ncbi Efficacy and cost of HMG-CoA reductase inhibitors in the treatment of patients with primary hyperlipidemia
    S Perreault
    University of Montreal, Montreal, Canada
    Can J Clin Pharmacol 7:144-54. 2000
    ..The choice of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) and the dose level may have significant implications for both efficient and cost effective therapy...
  2. pmc Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention
    S Perreault
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec H3C 3J7, Canada
    Br J Clin Pharmacol 59:564-73. 2005
    ..The objective was to evaluate the persistence rate of middle-aged patients initiating a statin therapy and its relation with several determinants for primary and secondary prevention...